RAVETCH JEFFREY V has a total of 12 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUNOQURE AG, PFEIFER ANDREA and DYAX CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Fermentation | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Ravetch Jeffrey V | 12 |
#2 | Nimmerjahn Falk | 4 |
#3 | Kaneko Yoshikatsu | 4 |
#4 | Anthony Robert M | 2 |
#5 | Pincetic Andrew | 1 |
#6 | Fukuyama Hidehiro | 1 |
#7 | Li Fubin | 1 |
#8 | Anthony Robert | 1 |
#9 | Falk Nimmerjahn | 1 |
#10 | Ott Rene G | 1 |
Publication | Filing date | Title |
---|---|---|
US8618251B1 | Fc mutants | |
US2008206246A1 | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
US2010189714A1 | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods | |
US2010278808A1 | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |